p53-independent downregulation of p73 in human cancer cells treated with Adriamycin

Cancer Chemotherapy and Pharmacology

Volumn 47, Issue 2, 2001, Pages 161-169

  Yuan, R ^a   Meng, Q ^a   Hu, H ^a   Goldberg, I D ^a   Rosen, E M ^a   Fan, S ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Adriamycin; Cancer; p53; p73; Proteasome inhibitor

Indexed keywords

DNA; DOXORUBICIN; MESSENGER RNA; MUTANT PROTEIN; PROTEASOME INHIBITOR; PROTEIN P53; PROTEIN P73; TRYPAN BLUE;

ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DNA DAMAGE; DOSE TIME EFFECT RELATION; DRUG CYTOTOXICITY; GENE DELETION; GENE MUTATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ANTIBIOTICS, ANTINEOPLASTIC; CYSTEINE ENDOPEPTIDASES; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DOXORUBICIN; GENES, P53; GENES, TUMOR SUPPRESSOR; HUMANS; MULTIENZYME COMPLEXES; NUCLEAR PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; RNA, MESSENGER; TIME FACTORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0034913019     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800000196     Document Type: Article

References (43)

1. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers
2. Mutation, allelotyping, and transcription analyses of the p73 gene in prostatic carcinoma
3. Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers
4. Alterations of p73 preferentially occur in gastric adenocarcinomas with foveolar epithelial phenotype
5. Loss of imprinting and allele switching of p73 in renal cell carcinoma
6. Overexpression of the wild type p73 gene in breast cancer tissues and cell lines
7. Frequent loss of heterozygosity at 1p36 in ovarian adenocarcinomas but the gene encoding p73 is unlikely to be the target
8. Loss of expression or mutations in the p73 tumour suppressor gene are not involved in the pathogenesis of malignant melanomas
9. Mutational and expression analysis of the p73 gene in melanoma cell lines
10. Absence of mutation of the p73 gene localized at chromosome 1p36.3 in hepatocellular carcinoma
11. Expression level, allelic origin, and mutation analysis of the p73 gene in neuroblastoma tumors and cell lines
12. p73, a gene related to p53, is not mutated in esophageal carcinomas
13. p73 is a human p53-related protein that can induce apoptosis
14. The potential tumor suppressor p73 differentially regulates cellular p53 target genes
15. Mdm2 binds p73 alpha without targeting degradation
16. Promoter specificity and stability control of the p53-related protein p73
17. p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage
18. Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis
19. Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis
20. p73 function is inhibited by tumor-derived p53 mutants in mammalian cells
21. New p73 variants with altered C-terminal structures have varied transcriptional activities
22. Inactivation of the p53-homologue p73 by the mdm2-oncoprotein
23. MDM 2 and MDMX bind and stabilize the p53-related protein p73
24. Viral oncoproteins discriminate between p53 and the p53 homolog p73
25. Inactivation of p53 but not p73 by adenovirus type 5 E1B 55-kilodalton and E4 34-kilodalton oncoproteins
26. The large T antigen of simian virus 40 binds and inactivates p53 but not p73
27. Adenovirus E4orf6 oncoprotein modulates the function of the p53-related protein, p73
28. The yeast two-hybrid system reveals no interaction between p73 alpha and SV40 large T-antigen
29. p53-independent decrease of p21 proteins caused by UV radiation in human cancer cells
30. BRCA1 as a potential human prostate tumor suppressor: Modulation of proliferation damage responses and expression of cell regulatory proteins
31. In vivo ubiquitination and proteasome-mediated degradation of p53
32. Co-ordinate alterations in the expression of BRCA1 BRCA2 p300 and Rad51 in response to genotoxic and other stresses in human prostate cancer cells
33. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
34. Localization of a breast cancer susceptibility gene BRCA2 to chromosome 13q12-q13
35. Germ-line BRCA1 mutations in selected men with prostate cancer
36. The tumor suppressor gene BRCA1 is required for embryonic cellular proliferation in the mouse
37. Double indemnity: p53 BRCA and cancer. P53 mutation partially rescues developmental arrest in Brca1 and Brca2 null mice suggesting a role for familial breast cancer genes in DNA repair
38. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins
39. p53 is linked directly to homologous recombination processes via RAD51/RecA protein interaction
40. Recruitment of p300/CBP in p53-dependent signal pathways
41. Role of p300 pocket proteins and hTBP in E1A-mediated transcriptional regulation and inhibition of p53 transactivation activity
42. Solution structure of a conserved C-terminal domain of p73 with structural homology to the SAM domain
43. p53 family members p63 and p73 are SAM domain-containing proteins